Tascom Co Ltd
336040
Company Profile
Business description
Tascom Co Ltd, formerly YIDOBIO Inc is a diabetes specialty company in Korea. The company develop cell therapy for the treatment of diabetes. It also manufactures and distributes diabetic supplies. The company's products include Blood glucose measurement system-acuraview, BD Ultra Fine PRO Pen Needle, Syringes-BD Ultrafine Syringes, Ido Sharp Container, and Ido safety lancet.
Contact
43 BanPo-daero 28-gil
5th Floor, i-SENS Building
SeoCho-gu
Seoul
KORT: +82 802232525
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
Employees
35
Stocks News & Analysis
stocks
Short-term pain for long-term gain for undervalued ASX share
Cost reductions lower our profit estimates but should lead to improved long-term outcomes.
stocks
Qantas earnings: Jetstar capitalising on weaker domestic competition
Qantas’ budget brand performing well, with segment earnings up 55%.
stocks
Nvidia Earnings: No signs of a slowdown in demand for AI chips
A selloff in Nvidia stock on the earnings news looks like a buying opportunity to us.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,028.30 | 98.90 | -1.08% |
| CAC 40 | 7,654.25 | 53.65 | -0.70% |
| DAX 40 | 23,487.33 | 550.00 | -2.29% |
| Dow JONES (US) | 45,295.81 | 249.07 | -0.55% |
| FTSE 100 | 9,116.69 | 79.65 | -0.87% |
| HKSE | 25,395.16 | 101.39 | -0.40% |
| NASDAQ | 21,279.63 | 175.92 | -0.82% |
| Nikkei 225 | 41,945.68 | 364.81 | -0.86% |
| NZX 50 Index | 13,054.58 | 78.58 | -0.60% |
| S&P 500 | 6,415.54 | 44.72 | -0.69% |
| S&P/ASX 200 | 8,757.70 | 101.30 | -1.14% |
| SSE Composite Index | 3,820.98 | 37.15 | -0.96% |